Ai m: To assess whether or not the parameters of fixed and randomized saccadic movements, of pendular tracking and of optokinetic nystagmus in the digital vectonystagmography may show abnormalities in patients with possible diagnosis of peripheral vestibular dysfunction. Method: 60 patients with dizziness of peripheral vestibular origin, from 12 to 82 years of age, males and females, were evaluated in the Universidade Federal de São Paulo. Ocular movement parameter findings were compared to a normal pattern. Results: Fixed saccadic movements were altered in 100% of the cases as to latency, and in 35.0% of the cases as to speed; the randomized saccadic movements were altered in 100% of the cases as to latency, in 78.3% as to precision, and in 1.7% as to speed; the pendular tracking showed a gain alteration in the frequencies of 0.1 Hz in 15% of the cases, 0.2 Hz in 21.7%, and 0.4 Hz in 13.3%; the optokinetic nystagmus showed an alteration of the angular speed in the slow component in 1.7% of the cases, and in gain in 5.0%. Conclusion: Fixed saccadic movement latency and speed, randomized saccadic movement latency, precision and speed, pendular tracking gain, slow component angular speed, and optokinetic nystagmus gain in the digital vectonystagmography may show abnormalities in patients with possible diagnosis of peripheral vestibular dysfunction.
Fixed saccadic movement latency and speed, randomized saccadic movement latency, precision and speed, pendular tracking gain, slow component angular speed, and optokinetic nystagmus gain in the digital vectonystagmography may show abnormalities in patients with possible diagnosis of peripheral vestibular dysfunction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.